These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 29548885

  • 21. Behavioral characterization of serotonergic activation in the flatworm Planaria.
    Farrell MS, Gilmore K, Raffa RB, Walker EA.
    Behav Pharmacol; 2008 May; 19(3):177-82. PubMed ID: 18469535
    [Abstract] [Full Text] [Related]

  • 22. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C, Seyfried CA.
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [Abstract] [Full Text] [Related]

  • 23. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.
    Bagdy G, Graf M, Anheuer ZE, Modos EA, Kantor S.
    Int J Neuropsychopharmacol; 2001 Dec; 4(4):399-408. PubMed ID: 11806866
    [Abstract] [Full Text] [Related]

  • 24. Serotonin modifies the spontaneous spiking activity of gracile nucleus neurons in rats: role of 5-HT1A and 5-HT2 receptors.
    Grasso C, Li Volsi G, Barresi M.
    Arch Ital Biol; 2016 Jun 01; 154(2-3):39-49. PubMed ID: 27918061
    [Abstract] [Full Text] [Related]

  • 25. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
    Zhang H, Wang W, Jiang Z, Shang J, Zhang L.
    Arzneimittelforschung; 2010 Jun 01; 60(3):109-15. PubMed ID: 20422941
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Anxiolytic effects of 5-HT₁A receptors and anxiogenic effects of 5-HT₂C receptors in the amygdala of mice.
    Li Q, Luo T, Jiang X, Wang J.
    Neuropharmacology; 2012 Jan 01; 62(1):474-84. PubMed ID: 21925519
    [Abstract] [Full Text] [Related]

  • 32. 5-HT1A agonist alleviates serotonergic potentiation of extrapyramidal disorders via postsynaptic mechanisms.
    Shimizu S, Mizuguchi Y, Tatara A, Kizu T, Andatsu S, Sobue A, Fujiwara M, Morimoto T, Ohno Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct 01; 46():86-91. PubMed ID: 23838274
    [Abstract] [Full Text] [Related]

  • 33. Serotonin 2C receptors in the basolateral amygdala mediate the anxiogenic effect caused by serotonergic activation of the dorsal raphe dorsomedial subnucleus.
    Matthiesen M, Mendes LD, Spiacci A, Fortaleza EA, Corrêa FM, Zangrossi H.
    J Psychopharmacol; 2020 Apr 01; 34(4):391-399. PubMed ID: 31637976
    [Abstract] [Full Text] [Related]

  • 34. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME, Cryan JF, Sullivan A, Dalvi A, Saucy B, Manning DR, Lucki I.
    J Pharmacol Exp Ther; 2002 Sep 01; 302(3):1220-7. PubMed ID: 12183683
    [Abstract] [Full Text] [Related]

  • 35. Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray.
    de Bortoli VC, Nogueira RL, Zangrossi H.
    Psychopharmacology (Berl); 2006 Jan 01; 183(4):422-8. PubMed ID: 16258751
    [Abstract] [Full Text] [Related]

  • 36. Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors.
    Zhang J, Huang XY, Ye ML, Luo CX, Wu HY, Hu Y, Zhou QG, Wu DL, Zhu LJ, Zhu DY.
    J Neurosci; 2010 Feb 17; 30(7):2433-41. PubMed ID: 20164327
    [Abstract] [Full Text] [Related]

  • 37. Involvement of dorsal raphe nucleus and dorsal periaqueductal gray 5-HT receptors in the modulation of mouse defensive behaviors.
    Pobbe RL, Zangrossi H, Blanchard DC, Blanchard RJ.
    Eur Neuropsychopharmacol; 2011 Apr 17; 21(4):306-15. PubMed ID: 20570114
    [Abstract] [Full Text] [Related]

  • 38. Indirect in vivo 5-HT1A-agonistic effects of the new antidepressant mirtazapine.
    Berendsen HH, Broekkamp CL.
    Psychopharmacology (Berl); 1997 Oct 17; 133(3):275-82. PubMed ID: 9361334
    [Abstract] [Full Text] [Related]

  • 39. Role of 5-hydroxytryptamine2C receptors in marble-burying behavior in mice.
    Egashira N, Okuno R, Shirakawa A, Nagao M, Mishima K, Iwasaki K, Oishi R, Fujiwara M.
    Biol Pharm Bull; 2012 Oct 17; 35(3):376-9. PubMed ID: 22382324
    [Abstract] [Full Text] [Related]

  • 40. Sex differences in the reversal of fluoxetine-induced anorexia following raphe injections of 8-OH-DPAT.
    Currie PJ, Braver M, Mirza A, Sricharoon K.
    Psychopharmacology (Berl); 2004 Apr 17; 172(4):359-64. PubMed ID: 14647961
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.